Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms
Aurobindo Pharma | Photo Credit: The Hindu Generic drugmaker Aurobindo Pharma reported a 25.2% year-on-year (YoY) increase in consolidated net profit to ₹1,032 crore in the June quarter FY27. The higher net profitability came on a 16.3% YoY increase in revenue from operations to ₹9,150 crore on the back of growth across businesses. Formulations revenue…
Read More “Aurobindo Pharma Q1 net rises 25% to ₹1,032 cr; approves merger of three arms” »